Skip to content

Bioventus BVS Cash ratio

Cash ratio at other companies

Stryker logo
StrykerSYK
0.5×+0.2×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
0.7×+0.3×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
0.1×-0.5×
Medtronic logo
MedtronicMDT
0.2×0.0×
Artivion logo
ArtivionAORT
0.6×-0.1×
Globus Medical logo
Globus MedicalGMED
1.2×0.0×

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Calculated from Bioventus’s reported figures.

Based on the most recent quarter.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's cash ratio?
Bioventus (BVS) reported cash ratio of 0.2× in Q1 2026.
How has Bioventus's cash ratio changed year-over-year?
Bioventus's cash ratio increased by 85.4% year-over-year, from 0.1× to 0.2×.
What is the long-term trend for Bioventus's cash ratio?
Over 5 years (2020 to 2025), Bioventus's cash ratio has grown at a -14.7% compound annual growth rate (CAGR), from 0.7× to 0.3×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.